HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cognis certified natural

This article was originally published in The Rose Sheet

Executive Summary

Raw materials supplier Cognis says 30 of its cosmetic oils, emulsifiers and surfactants have been certified for use in natural personal-care products by BDIH (Association of German Industries and Trading Firms). Noting the booming demand for "green" personal care, Cognis says that "up until now, manufacturers of cosmetics and personal hygiene products who wanted their end products to be awarded [BDIH's] official seal had to ask Cognis to fill out a lengthy form with details about the raw materials used. But now that Cognis has obtained certification for its ingredients, it is much simpler for [its] Care Chemicals customers to formulate natural cosmetics that comply with the BDIH guidelines." More than 130 companies - including 25 outside of Germany - market products that bear BDIH's stamp of approval, according to Cognis, which maintains the seal gives companies "a clear competitive advantage," especially in German-speaking markets. Other Cognis offerings currently are being evaluated for BDIH certification, firm notes. Ninety Cognis ingredients are "green" by Ecocert standards, it adds...

You may also be interested in...

Warning Letter Close-Outs – March 2020

The US FDA released five device-related close-out letters in March.

Medicines Must Be Designated As Priority Items, Says IGBA

Governments around the world should designate all medicines as ‘priority essential products’, the IGBA has urged, as a surge in demand coinciding with a reduction in the number of flights and rising freight costs are making it more difficult for suppliers to meet global requirements amid the coronavirus pandemic.

COVID-19: FDA Will Hold Remote Meetings With Firms, Extends Marketing Application Due Dates

In a letter to the medtech industry, the FDA’s William Maisel says the US agency will hold remote meetings with device makers and other stakeholders through the end of May. The FDA also extended due dates for marketing applications by 90 days.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts